Back to Search
Start Over
Prenatal Screening for Microdeletions and Rare Autosomal Aneuploidies.
- Source :
-
Clinical Obstetrics & Gynecology . Sep2023, Vol. 66 Issue 3, p579-594. 16p. - Publication Year :
- 2023
-
Abstract
- Noninvasive prenatal screening with cell-free DNA is now considered a first-line screening for common aneuploidies. Advancements in existing laboratory techniques now allow to interrogate the entirety of the fetal genome, and many commercial laboratories have expanded their screening panels to include screening for rare autosomal aneuploidies and copy number variants. Here, we review the currently available data on the performance of fetal cell-free DNA to detect rare autosomal aneuploidies and copy number variants that are associated with clinically significant microdeletion and microduplication syndromes and the current position of medical societies on routine screening for these syndromes. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 00099201
- Volume :
- 66
- Issue :
- 3
- Database :
- Academic Search Index
- Journal :
- Clinical Obstetrics & Gynecology
- Publication Type :
- Academic Journal
- Accession number :
- 175570903
- Full Text :
- https://doi.org/10.1097/GRF.0000000000000799